Summary
The cytoplasmic islet cell antibody patterns of sera from islet cell antibody positive non-diabetic and diabetic endocrine autoimmune patients, and newly-diagnosed Type 1 (insulin-dependent) diabetic patients were characterised using four layer immunofluorescence with monoclonal antiproinsulin or anti-glucagon antibodies. Two distinct islet cell antibody types were identified. One gave a diffuse cytoplasmic staining in both Beta and Alpha cells (‘whole’ islet pattern), and was not affected by pre-incubation with rat brain homogenate. The other had a granular appearance with staining restricted predominantly to Beta cells (‘selective’ islet pattern) and was completely inhibited by pre-incubation with rat brain homogenate. Some sera appeared to have a ‘mixed’ islet pattern, in which glucagon-positive cells gave a weaker cytoplasmic staining than proinsulin-positive cells. The granular ‘selective’ pattern was found in sera from 19 (79%) of 24 non-diabetic endocrine autoimmune patients, in two (22%) endocrine autoimmune patients who developed Type 1 diabetes (p<0.0001 vs non-diabetic endocrine autoimmune patients), and in none of 19 newly-diagnosed diabetic patients. The ‘whole’ islet pattern was found only in sera from patients who had, or who subsequently progressed to, Type 1 diabetes. This study has identified a novel islet cell antibody specificity and demonstrates that in islet cell antibody positive endocrine autoimmune patients, only islet cell antibodies which stain both Beta and Alpha cells are associated with progression to Type 1 diabetes.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bonifacio E, Bottazzo GF (1991) Immunology of IDDM (Type I diabetes) — entering the '90s. In: Alberti KGMM, Krall LP (eds) The diabetes annual/6. Elsevier, Amsterdam, pp 20–47
Pilcher CC, Elliot RB (1990) A sensitive and reproducible method for the assay of human islet cell antibodies. J Immunol Meth 129: 111–117
Bonifacio E, Bingley P, Shattock M et al. (1990) Quantification of islet cell antibodies and prediction of insulin-dependent diabetes. Lancet 335: 147–149
Bosi E, Becker F, Bonifacio E et al. (1991) Progression to Type I (insulin-dependent) diabetes in autoimmune endocrine patients with islet cell antibodies. Diabetes 40: 977–984
Bottazzo GF, Lendrum R (1976) Separate autoantibodies to human pancreatic glucagon and somatostatin cells. Lancet II: 873–876
Bottazzo GF, Doniach D (1978) Islet cell antibodies (ICA) in diabetes mellitus: evidence of an autoantigen common to all the cells in the islet of Langerhans. Ric Clin Lab 8: 29–38
Baekkeshov S, Aanstoot H-K, Christgau S et al. (1990) Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151–156
Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P (1990) Autoantibodies to GABA-ergic neurons and pancreatic Beta-cells in stiff-man syndrome. N Engl J Med 322: 1555–1560
Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark Å, Sundkvist G (1989) Islet cell and other organ-specific autoantibodies in all children developing Type 1 (insulin-dependent) diabetes mellitus in Sweden during one-year and in matched control children. Diabetologia 32: 387–395
Gianani R, Pugliese A, Bonner-Wier S, Shiffrin AJ, Soelcher JS, Erlich H, Awdeh Z, Alper CA, Jackson RA, Eisenbarth GS (1992) Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type 1 diabetes. Diabetes (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Genovese, S., Bonifacio, E., McNally, J.M. et al. Distinct cytoplasmic islet cell antibodies with different risks for Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35, 385–388 (1992). https://doi.org/10.1007/BF00401207
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00401207